AbbVie Defends Its Turf, But Leaves One Big Question Open
Yahoo Finance · Aug 14, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)
AbbVie's growth engine is firing on all cylinders, but on its latest earnings call, analysts focused on whether the company can defend its turf and execute on its next big pipeline bet.
Not investment advice. Cached headline, not a full reprint.